88 related articles for article (PubMed ID: 56853)
1. Demonstration of 3-methoxytyrosine in the urine of melanoma patients.
Agrup G; Bengtsson M; Falck B; Persson K; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1976; 56(1):27-31. PubMed ID: 56853
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
Agrup G; Agrup P; Andersson T; Falck B; Hansson J-A ; Jacobsson S; Rorsman H; Rosengrem A-M ; Rosengren E
Acta Derm Venereol; 1975; 55(5):337-41. PubMed ID: 52967
[TBL] [Abstract][Full Text] [Related]
3. 5-S-cysteinyldopa in the urine of melanoma patients.
Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
[TBL] [Abstract][Full Text] [Related]
4. 5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid.
Agrup G; Andersson T; Falck B; Persson K; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1975; 55(1):5-6. PubMed ID: 46673
[TBL] [Abstract][Full Text] [Related]
5. [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
Paul E; Graef V; Ruppel R; Hellwich M
Z Hautkr; 1983 Feb; 58(4):262-5. PubMed ID: 6405551
[TBL] [Abstract][Full Text] [Related]
6. [Urinary 5-S-cysteinyldopa levels in patients with malignant melanoma. Preliminary results].
Césarini JP; Meunier M
Rev Prat; 1975 Nov; 25(51):4037-9. PubMed ID: 1209143
[No Abstract] [Full Text] [Related]
7. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of determining spermidine in the urine of patients with melanoblastoma of the skin].
Smirnova EV; Khachaturian LM
Vopr Onkol; 1976; 22(11):78-81. PubMed ID: 1014507
[TBL] [Abstract][Full Text] [Related]
9. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
Stewart RM; Miller S; Gunder M
Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
[TBL] [Abstract][Full Text] [Related]
10. [Chemical diagnosis of melanoma].
Agrup G
Lakartidningen; 1976 Feb; 73(7):526-8. PubMed ID: 1250044
[No Abstract] [Full Text] [Related]
11. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
Morishima T; Tatsumi F; Fukada E; Saito M; Fujita M; Nagashima N; Hanawa S
Arch Dermatol Res; 1983; 275(2):76-9. PubMed ID: 6409012
[TBL] [Abstract][Full Text] [Related]
12. A qualitative gas chromatographic analysis of substituted 5,6-dihydroxyindoles from the urine of patients with melanoma.
Pavel S; Muskiet FA; Budesínská A; Duchon J
Tumori; 1981 Aug; 67(4):325-32. PubMed ID: 6797117
[TBL] [Abstract][Full Text] [Related]
13. [Urinary 5-S-cysteinyldopa in malignant melanoma subjects-with special reference to melanoma stages and dopa loading test (author's transl)].
Ichihasi M; Mojamdar M; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1981 Sep; 91(10):1045-9. PubMed ID: 6798247
[No Abstract] [Full Text] [Related]
14. [Melanoma metabolites (proceedings)].
Rorsman H
Lakartidningen; 1978 Dec; 75(49):4596-7. PubMed ID: 723347
[No Abstract] [Full Text] [Related]
15. Detection of occult metastatic melanoma by urine chromatography.
Blois MS; Banda PW
Cancer Res; 1976 Sep; 36(9 pt.1):3317-23. PubMed ID: 975093
[TBL] [Abstract][Full Text] [Related]
16. [Increased excretion of indolemelanogens in malignant melanoma without liver metastasis].
Schwartze G; Haneke E
Dermatol Monatsschr; 1969; 155(2):99-102. PubMed ID: 5386292
[No Abstract] [Full Text] [Related]
17. [5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations].
Paul E; Graef V; Ruppel R
Z Hautkr; 1980 Dec; 55(23):1543-60. PubMed ID: 6782780
[TBL] [Abstract][Full Text] [Related]
18. Trichochromuria in melanosis of melanoma.
Rorsman H; Agrup P; Carlén B; Hansson C; Jonsson N; Rosengren E; Tegner E
Acta Derm Venereol; 1986; 66(6):468-73. PubMed ID: 2433864
[TBL] [Abstract][Full Text] [Related]
19. [Excretion of 3-4-dihydroxyphenyloalanin (DOPA) in the urine of patients with malignant melanoma of the organ of vision].
Kruszczyński T
Klin Oczna; 1972; 42(2):687-91. PubMed ID: 5022207
[No Abstract] [Full Text] [Related]
20. Trichochromes in the urine of melanoma patients.
Agrup G; Lindbladh C; Prota G; Rorsman H; Rosengren AM; Rosengren E
J Invest Dermatol; 1978 Feb; 70(2):90-1. PubMed ID: 621413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
